|
and Sponsors                    |
|||||||||||
  |
The Continuing Education activities below will remain active for 12 months from the date of publication. You will be able to do any one of them at any time. ie ALL activities remain 'active' not just the current activity. While every effort has been made to ensure that material presented is accurate and up to date, new evidence is continually uncovered and what is accurate one week may not stay accurate for long.
AusPharm Continuing Education
After completing this activity, pharmacists should be able to:
PSA is authorised by the Australian Pharmacy Council to accredit providers of CPD activities for pharmacists that may be used as supporting evidence of continuing competence. Click here to do this Continuing Education activity.
Click here to do this Continuing Education activity.
Learning objectives After completing this activity, pharmacists should be able to:
PSA is authorised by the Australian Pharmacy Council to acredit providers of CPD activities for pharmacists that may be used as supporting evidence of continuing competence. Click here to do this Continuing Education activity.
Click here to do this Continuing Education activity.
Learning objectives After completing this activity, pharmacists should be able to:
PSA is authorised by the Australian Pharmacy Council to acredit providers of CPD activities for pharmacists that may be used as supporting evidence of continuing competence. Click here to do this Continuing Education activity.
Click here to do this Continuing Education activity.
Learning objectives After completing this activity, pharmacists should be able to:
PSA is authorised by the Australian Pharmacy Council to accredit providers of CPD activities for pharmacists that may be used as supporting evidence of continuing competence. Click here to do this Continuing Education activity.
Click here to do this Continuing Education activity.
Learning objectives After completing this activity, pharmacists should be able to:
Click here to do this Continuing Education activity.
Click here to do this Continuing Education activity.
After completing this activity, pharmacists should be able to:
PSA is authorised by the Australian Pharmacy Council to accredit providers of CPD activities for pharmacists that may be used as supporting evidence of continuing competence. Click here to do this Continuing Education activity.
Click here to do this Continuing Education activity.
PSA is authorised by the Australian Pharmacy Council to acredit providers of CPD activities for pharmacists that may be used as supporting evidence of continuing competence. Click here to do this Continuing Education activity.
Click here to do this Continuing Education activity.
After completing this activity, pharmacists should be able to:
PSA is authorised by the Australian Pharmacy Council to accredit providers of CPD activities for pharmacists that may be used as supporting evidence of continuing competence. Click here to do this Continuing Education activity.
Click here to do this Continuing Education activity.
PSA is authorised by the Australian Pharmacy Council to acredit providers of CPD activities for pharmacists that may be used as supporting evidence of continuing competence. Click here to do this Continuing Education activity.
Click here to do this Continuing Education activity.
After completing this activity, pharmacists should be able to discuss:
PSA is authorised by the Australian Pharmacy Council to acredit providers of CPD activities for pharmacists that may be used as supporting evidence of continuing competence. Click here to do this Continuing Education activity.
Click here to do this Continuing Education activity.
PSA is authorised by the Australian Pharmacy Council to acredit providers of CPD activities for pharmacists that may be used as supporting evidence of continuing competence. Click here to do this Continuing Education activity.
Click here to do this Continuing Education activity.
After completing this activity, pharmacists should be able to:
PSA is authorised by the Australian Pharmacy Council to acredit providers of CPD activities for pharmacists that may be used as supporting evidence of continuing competence. Click here to do this Continuing Education activity.
Click here to do this Continuing Education activity.
PSA is authorised by the Australian Pharmacy Council to acredit providers of CPD activities for pharmacists that may be used as supporting evidence of continuing competence. Click here to do this Continuing Education activity.
Click here to do this Continuing Education activity.
After completing this activity, pharmacists should be able to:
PSA is authorised by the Australian Pharmacy Council to acredit providers of CPD activities for pharmacists that may be used as supporting evidence of continuing competence. Click here to do this Continuing Education activity.
Click here to do this Continuing Education activity.
PSA is authorised by the Australian Pharmacy Council to acredit providers of CPD activities for pharmacists that may be used as supporting evidence of continuing competence. Click here to do this Continuing Education activity.
Click here to do this Continuing Education activity.
PSA is authorised by the Australian Pharmacy Council to acredit providers of CPD activities for pharmacists that may be used as supporting evidence of continuing competence. Click here to do this Continuing Education activity.
Click here to do this Continuing Education activity.
After completing this activity, pharmacists should be able:
PSA is authorised by the Australian Pharmacy Council to acredit providers of CPD activities for pharmacists that may be used as supporting evidence of continuing competence. Competency: The competency standards addressed by this activity include 3.2.6 (at least). Click here to do this Continuing Education activity.
Click here to do this Continuing Education activity.
After completing this activity, pharmacists should be able to:
PSA is authorised by the Australian Pharmacy Council to acredit providers of CPD activities for pharmacists that may be used as supporting evidence of continuing competence. Click here to do this Continuing Education activity.
Click here to do this Continuing Education activity.
PSA is authorised by the Australian Pharmacy Council to acredit providers of CPD activities for pharmacists that may be used as supporting evidence of continuing competence. Click here to do this Continuing Education activity.
Click here to do this Continuing Education activity.
Learning objectives:
The competency standards addressed by this activity include (but may not be limited to) 3.1.2.; 3.1.3; 3.1.5; 3.2.2; 4.2.1; 4.2.2; 4.2.3, 7.3.2; 7.3.4. Successfull completion of this activity is demonstrated by answering five of the six multiple choice questions correctly. PSA is authorised by the Australian Pharmacy Council to acredit providers of CPD activities for pharmacists that may be used as supporting evidence of continuing competence. Click here to do this Continuing Education activity.
Click here to do this Continuing Education activity.
After completing this activity, pharmacists should be able to:
PSA is authorised by the Australian Pharmacy Council to acredit providers of CPD activities for pharmacists that may be used as supporting evidence of continuing competence. Click here to do this Continuing Education activity.
Click here to do this Continuing Education activity.
After completing this activity, pharmacists should be able to:
PSA is authorised by the Australian Pharmacy Council to acredit providers of CPD activities for pharmacists that may be used as supporting evidence of continuing competence. Click here to do this Continuing Education activity.
Click here to do this Continuing Education activity.
PSA is authorised by the Australian Pharmacy Council to acredit providers of CPD activities for pharmacists that may be used as supporting evidence of continuing competence. Click here to do this Continuing Education activity.
Click here to do this Continuing Education activity.
After completing this activity, pharmacists should be able to:
PSA is authorised by the Australian Pharmacy Council to acredit providers of CPD activities for pharmacists that may be used as supporting evidence of continuing competence. Click here to do this Continuing Education activity.
Click here to do this Continuing Education activity.
After completing this activity, pharmacists should be able to:
PSA is authorised by the Australian Pharmacy Council to acredit providers of CPD activities for pharmacists that may be used as supporting evidence of continuing competence. Click here to do this Continuing Education activity.
Click here to do this Continuing Education activity.
PSA is authorised by the Australian Pharmacy Council to acredit providers of CPD activities for pharmacists that may be used as supporting evidence of continuing competence. Click here to do this Continuing Education activity.
Click here to do this Continuing Education activity.
Learning objectives After completing this activity, pharmacists should be able to:
Click here to do this Continuing Education activity.
Click here to do this Continuing Education activity.
After completing this activity, pharmacists should be able to:
PSA is authorised by the Australian Pharmacy Council to acredit providers of CPD activities for pharmacists that may be used as supporting evidence of continuing competence. Click here to do this Continuing Education activity.
Click here to do this Continuing Education activity.
After completing this activity, pharmacists should be able to:
Click here to do this Continuing Education activity.
Click here to do this Continuing Education activity.
* Interaction between folate and phenytoin
Click here to do this Continuing Education activity.
Click here to do this Continuing Education activity.
After completing this activity, pharmacists should be able to:
This activity has been accredited by the Pharmaceutical Society of Australia as a Group 2 activity for 1 point. Accreditation number: CX090022z. Click here to do this Continuing Education activity.
Click here to do this Continuing Education activity.
After completing this activity, pharmacists should be able to:
Click here to do this Continuing Education activity.
Click here to do this Continuing Education activity.
After completing this activity, pharmacists should be able to:
Click here to do this Continuing Education activity.
Click here to do this Continuing Education activity.
* Total parenteral nutrition
Click here to do this Continuing Education activity.
Click here to do this Continuing Education activity.
Competency standards addressed: 6.3.1, 7.3.2, 7.3.3, 8.4.3.
Click here to do this Continuing Education activity.
Click here to do this Continuing Education activity.
After completing this activity, pharmacists should be able to:
Click here to do this Continuing Education activity.
Click here to do this Continuing Education activity.
Learning objectives After completing this activity, pharmacists should be able to:
Click here to do this Continuing Education activity.
Click here to do this Continuing Education activity.
Click here to do this Continuing Education activity.
Click here to do this Continuing Education activity.
After completing this activity, pharmacists should be able to:
Click here to do this Continuing Education activity.
Click here to do this Continuing Education activity.
* Discuss the association between dietary fat intake and cardiovascular health Competency standards addressed: 6.3.1, 7.3.2, 7.3.3, 8.4.3.
Click here to do this Continuing Education activity.
Click here to do this Continuing Education activity.
Learning objectives After completing this activity, pharmacists should be able to:
This activity has been accredited by the Pharmaceutical Society of Australia as a Group 2 activity for 1.25 point. Accreditation number: CX090022p. Click here to do this Continuing Education activity.
Click here to do this Continuing Education activity.
After completing this activity, pharmacists should be able to:
Click here to do this Continuing Education activity.
Click here to do this Continuing Education activity.
After completing this activity, pharmacists should be able to:
The competency standards addressed by this activity include (but may not be limited to) 3.1.2.; 3.1.3; 3.1.5; 3.2.2; 4.2.1; 4.2.2; 4.2.3, 7.3.2; 7.3.4. This activity has been accredited by the Pharmaceutical Society of Australia as a Group 2 activity for 0.75 points. Accreditation number: CX090022o. Click here to do this Continuing Education activity.
Click here to do this Continuing Education activity.
The competency standards addressed by this activity include (but may not be limited to) 3.1, 3.2, 3.3, 6.1 ,6.2, 6.3.
Click here to do this Continuing Education activity.
Click here to do this Continuing Education activity.
After completing this activity, pharmacists should be able to:
The competency standards addressed by this activity include (but may not be limited to) 3.1.2.; 3.1.3; 3.1.5; 3.2.2; 4.2.1; 4.2.2; 4.2.3; 7.3.2; 7.3.4. This activity has been accredited by the Pharmaceutical Society of Australia as a Group 2 activity for 0.75 points. Accreditation number: CX090022l. Click here to do this Continuing Education activity.
Click here to do this Continuing Education activity.
Click here to do this Continuing Education activity. This activity has been accredited by the Pharmaceutical Society of Australia as a Group 2 activity for 1 point. Accreditation number: CX090022k.
Click here to do this Continuing Education activity.
The competency standards addressed by this activity include (but may not be limited to) 3.1.2, 3.1.3, 3.1.4.
Click here to do this Continuing Education activity.
AusPharm gratefully acknowledges the financial support provided by the sponsors of our CE program, MIMS and The Australian Medicines Handbook (AMH). Click here to do this Continuing Education activity.
Click here to do this Continuing Education activity.
Click here to do this Continuing Education activity.
After completing this activity, pharmacists should be able to:
The competency standards addressed by this activity include (but may not be limited to) 3.1.2.; 3.1.3; 3.1.5; 3.2.2; 4.2.1; 4.2.2; 4.2.3; 7.3.2; 7.3.4. This activity has been accredited by the Pharmaceutical Society of Australia as a Group 2 activity for 0.75 point. Accreditation number: CX090022h.
Click here to do this Continuing Education activity.
Click here to do this Continuing Education activity.
This activity has been accredited by the Pharmaceutical Society of Australia as a Group 2 activity for 1.25 points. Accreditation number: CX090022f. Click here to do this Continuing Education activity.
Click here to do this Continuing Education activity.
Competency standards addressed: 3.2.2, 6.1.1, 6.1.2, 6.1.3, 6.2.1, 6.2.2, 6.2.5, 6.3.2.
Click here to do this Continuing Education activity.
Click here to do this Continuing Education activity. RGH Pharmacy E-Bulletin CPD Digest - Issue No 9 :: : 5/3/2009 :
The competency standards addressed by this activity include (but may not be limited to) 3.1.2.; 3.1.3; 3.1.5; 3.2.2; 4.2.1; 4.2.2; 4.2.3; 7.3.2; 7.3.4. This activity has been accredited by the Pharmaceutical Society of Australia as a Group 2 activity for 1 point. Accreditation number: CX090022a.
Click here to do this Continuing Education activity.
Competency standards addressed: 3.1.2 and 4.3.3
Click here to do this Continuing Education activity.  
AusPharm gratefully acknowledges the financial support provided by the sponsors of our CE program, MIMS and The Australian Medicines Handbook (AMH). Click here to do this Continuing Education activity.
* the causes of vaginitis; and
 * approaches to the management of vaginitis, particularly vulvovaginal candidiasis.The competency standards addressed by this activity include (but may not be limited to) 3.1.1, 3.1.2, 6.1.1, 6.1.2, 6.1.3, 6.2.1, 6.2.2, 6.3.1, 6.3.. This activity has been accredited by the Pharmaceutical Society of Australia as a Group 2 activity for 1 point. Accreditation number: CX090022a.
AusPharm gratefully acknowledges the financial support provided by the sponsors of our CE program, MIMS and The Australian Medicines Handbook (AMH). Click here to do this Continuing Education activity.
The competency standards addressed by this activity include (but may not be limited to) 3.1.2 and 4.3.3.
 AusPharm gratefully acknowledges the financial support provided by the sponsors of our CE program, MIMS and The Australian Medicines Handbook (AMH). Click here to do this Continuing Education activity. RGH Pharmacy E-Bulletin CPD Digest - Issue No 8 :: : 16/12/2008 :
The RGH Pharmacy E-Bulletin CPD Digest is a new way for busy pharmacists, doctors and nurses to access high quality continuing professional development materials in a convenient, inexpensive and reliable format. Click here to do this Continuing Education activity.   AusPharm gratefully acknowledges the financial support provided by the sponsors of our CE program, MIMS and The Australian Medicines Handbook (AMH). Click here to do this Continuing Education activity.
Chocolate for some is an everyday consumption, at any hour of the day. Cocoa is the third largest commodity on the world market, after sugar and coffee. The Swiss lead the world in chocolate consumption at roughly 10kg per person per year. Recent evidence suggests that chocolate has beneficial effects of lipids and blood pressure, and may contribute to prevention of cardiovascular disease as part of a healthy lifestyle. Click here to do this Continuing Education activity. AusPharm gratefully acknowledges the financial support provided by the sponsors of our CE program, MIMS and The Australian Medicines Handbook (AMH). Click here to do this Continuing Education activity. RGH Pharmacy E-Bulletin CPD Digest - Issue No 7 :: : 2/12/2008 :
The RGH Pharmacy E-Bulletin CPD Digest is a new way for busy pharmacists, doctors and nurses to access high quality continuing professional development materials in a convenient, inexpensive and reliable format. Click here to do this Continuing Education activity. AusPharm gratefully acknowledges the financial support provided by the sponsors of our CE program, MIMS and The Australian Medicines Handbook (AMH). Click here to do this Continuing Education activity.
"A young woman presents to the pharmacy because she has received a message on her answering machine from a sexual partner with whom she had unprotected sex one week ago. He has accused her of giving him herpes.
Not a 'premium' member? To upgrade now click here or to commence a free trial click here.
Click here to do this Continuing Education activity.
After completing this activity, the pharmacist should be able to:
Click here to do this Continuing Education activity now. AusPharm gratefully acknowledges the financial support provided by the sponsors of our CE program, MIMS and The Australian Medicines Handbook (AMH).Click here to do this Continuing Education activity.
Click here to do this Continuing Education activity now. Not a 'premium' member? To upgrade now click here or to commence a free trial click here. To add your PSA, AACP or ACPPM member number to our database (so you can receive credit for completing this activity) click here. AusPharm gratefully acknowledges the financial support provided by the sponsors of our CE program, MIMS and The Australian Medicines Handbook (AMH). Click here to do this Continuing Education activity. RGH Pharmacy E-Bulletin CPD Digest - Issue No 6 :: : 4/11/2008 :
The RGH Pharmacy E-Bulletin CPD Digest is a new way for busy pharmacists, doctors and nurses to access high quality continuing professional development materials in a convenient, inexpensive and reliable format. Click here to do this Continuing Education activity.  AusPharm gratefully acknowledges the financial support provided by the sponsors of our CE program, MIMS and The Australian Medicines Handbook (AMH). Click here to do this Continuing Education activity.
Click here to do this Continuing Education activity now. Not a 'premium' member? To upgrade now click here or to commence a free trial click here.
Click here to do this Continuing Education activity.
Concerns over the safety profile of rosiglitazone have lead to recent changes to the availability of this drug under the PBS. Click here to do this Continuing Education activity. AusPharm gratefully acknowledges the financial support provided by the sponsors of our CE program, MIMS and The Australian Medicines Handbook (AMH). Click here to do this Continuing Education activity.
Not a 'premium' member? To upgrade now click here or to commence a free trial click here. To add your PSA, AACP or ACPPM member number to our database (so you can receive credit for completing this activity) click here. AusPharm gratefully acknowledges the financial support provided by the sponsors of our CE program, MIMS and The Australian Medicines Handbook (AMH).
Click here to do this Continuing Education activity. RGH Pharmacy E-Bulletin CPD Digest - Issue No 5 :: : 7/10/2008 :
The RGH Pharmacy E-Bulletin CPD Digest is a new way for busy pharmacists, doctors and nurses to access high quality continuing professional development materials in a convenient, inexpensive and reliable format. Click here to do this Continuing Education activity. AusPharm gratefully acknowledges the financial support provided by the sponsors of our CE program, MIMS and The Australian Medicines Handbook (AMH). Click here to do this Continuing Education activity.
Two weeks ago AusPharm ran the first part of this two part series on Mens Health: Benign Prostatic Hyperplasia (BPH) Frank Axe is a 67-year old male. He presents in the pharmacy and asks for your advice. Discussion reveals that Frank has been getting up increasingly often at night to pass urine, he himself looses count how often, but his wife has told him that it is 5 or 6 times a night......" Click here to do this Continuing Education activity now. Not a 'premium' member? To upgrade now click here or to commence a free trial click here.
Click here to do this Continuing Education activity.
Click here to do this Continuing Education activity.
Learning Objective: The pharmacist should be able to apply evidence-based principles of pharmacotherapeutics to a practical example of a patient with a bacterial STI. Two weeks ago AusPharm ran the first part of this two part series on Sexually transmissible infections other than HIV – current management strategies A 19 year old woman presents to the pharmacy asking for something for “period pain”. She describes the pain as diffuse, mild lower abdominal pain that has occurred fairly continuously for the past six weeks. She also states that she has not suffered pain like this before with her menses. The only treatment she has used so far is a hot water bottle at night time, with little effect. Her only regular medication is Monofeme tablets, which she started about three months ago after needing the “morning-after” pill twice in a fortnight. Click here to do this Continuing Education activity now. Not a 'premium' member? To upgrade now click here or to commence a free trial click here.
Click here to do this Continuing Education activity.
Learning Objective: After completing this activity, the pharmacist should be able to discuss:
Benign hyperplasia of the prostate gland is an age-related condition, existing in more than 50% of men over 60 years of age, increasing to 90% in men over 80 years. In many men prostatic enlargement will be asymptomatic, but amongst men over 60 years of age, between 15% and 30% will have some Lower Urinary Tract Symptoms (LUTS) and one in four will have LUTS which greatly affect their quality of life. Click here to do this Continuing Education activity now. Not a 'premium' member? To upgrade now click here or to commence a free trial click here. To add your PSA, AACP or ACPPM member number to our database (so you can receive credit for completing this activity) click here. AusPharm gratefully acknowledges the financial support provided by the sponsors of our CE program, MIMS and The Australian Medicines Handbook (AMH).
Click here to do this Continuing Education activity. RGH Pharmacy E-Bulletin CPD Digest - Issue No 4 :: : 2/9/2008 : The RGH Pharmacy E-Bulletin CPD Digest is a new way for busy pharmacists, doctors and nurses to access high quality continuing professional development materials in a convenient, inexpensive and reliable format. Click here to do this Continuing Education activity. AusPharm gratefully acknowledges the financial support provided by the sponsors of our CE program, MIMS and The Australian Medicines Handbook (AMH).
Click here to do this Continuing Education activity.
Good asthma management requires appropriate treatment of allergic rhinitis. Most people with asthma (up to 80 percent) have allergic rhinitis and more than 60 per cent of people with allergic rhinitis also have asthma. Click here to do this Continuing Education activity.
AusPharm gratefully acknowledges the financial support provided by the sponsors of our CE program, MIMS and The Australian Medicines Handbook (AMH). Click here to do this Continuing Education activity.
The term sexually transmissible infection (STI) describes a multitude of diseases in which sexual behaviour plays an epidemiologically significant role in the transmission of the causative pathogen. Such diseases may also be transmitted via nonsexual routes. For example, not all infections due to human immunodeficiency virus (HIV) or hepatitis B virus (HBV) are transmitted sexually. Over 30 different infections are now classified as predominantly sexually transmitted or as frequently sexually transmissible. Click here to do this Continuing Education activity now. Not a 'premium' member? To upgrade now click here or to commence a free trial click here. To add your PSA, AACP or ACPPM member number to our database (so you can receive credit for completing this activity) click here. AusPharm gratefully acknowledges the financial support provided by the sponsors of our CE program, MIMS and The Australian Medicines Handbook (AMH).
Click here to do this Continuing Education activity.
Learning Objective: The pharmacist should be able to apply evidence-based principles of pharmacotherapeutics to a practical example of a patient with type 2 diabetes and overweight/obesity. Two weeks ago AusPharm ran the first part of this two part series on Eddie Green is a 61-year old male, who presents to his GP for a routine check-up. He states that “he feels pretty much the same since his last face-to-face visit almost one year ago, and everything seems to be going well”. The GP decides that a HMR could be useful as part of an overall review and education of Mr. Green, and provides the following data to Mr. Green’s community pharmacy. Click here to do this Continuing Education activity now. Not a 'premium' member? To upgrade now click here or to commence a free trial click here.
Click here to do this Continuing Education activity. RGH Pharmacy E-Bulletin CPD Digest - Issue No 3 :: : 5/8/2008 : The RGH Pharmacy E-Bulletin CPD Digest is a new way for busy pharmacists, doctors and nurses to access high quality continuing professional development materials in a convenient, inexpensive and reliable format. The Digest is based around the RGH Pharmacy E-Bulletin, which will continue to be distributed free of charge in the usual way. (Click here to read the RGH announcement in full.) Click here to do this Continuing Education activity. AusPharm gratefully acknowledges the financial support provided by the sponsors of our CE program, MIMS and The Australian Medicines Handbook (AMH).
Click here to do this Continuing Education activity.
Obesity and weight gain are major complications for type 2 diabetic patients, and nearly 90% of this patient group is considered overweight (BMI > 25 kg/m2) or obese (BMI > 30 kg/m2). Most of the patients suffer from ‘metabolic syndrome’ (see Table 1 for definition); the combination of being overweight accompanied by insulin resistance, hypertension, dyslipidaemia and hyperglycaemia. The question is how to manage weight in these patients, in whom weight loss is generally more difficult to achieve than in other obese individuals, and thereby improve diabetic control and prevent long-term complications. Click here to do this Continuing Education activity now. Not a 'premium' member? To upgrade now click here or to commence a free trial click here. To add your PSA, AACP or ACPPM member number to our database (so you can receive credit for completing this activity) click here. AusPharm gratefully acknowledges the financial support provided by the sponsors of our CE program, MIMS and The Australian Medicines Handbook (AMH).
Click here to do this Continuing Education activity.
After completing this activity, pharmacists should be able to:
AusPharm gratefully acknowledges the financial support provided by the sponsors of our CE program, MIMS and The Australian Medicines Handbook (AMH). Click here to do this Continuing Education activity.
Learning Objective: The pharmacist should be able to apply evidence-based principles of pharmacotherapeutics to a practical example of a patient with hyperhidrosis. Two weeks ago AusPharm ran the first part of this two part series on Hyperhidrosis. Participants will need to refer back to that activity and to other reference material (eg MIMs, AMH, eTG) in order to complete this case study. Mrs. Nolan is a 47-year-old woman, approaching menopause. She has a past history of hypertension and depression. Her current medications are diltiazem 180mg daily and sertraline 100 mg daily. She has presented to her GP with excessive, generalised sweating, which requires a change of clothing several times daily. Click here to do this Continuing Education activity now. Not a 'premium' member? To upgrade now click here or to commence a free trial click here.
Click here to do this Continuing Education activity. RGH Pharmacy E-Bulletin CPD Digest - Issue No 2 :: : 8/7/2008 : The RGH Pharmacy E-Bulletin CPD Digest is a new way for busy pharmacists, doctors and nurses to access high quality continuing professional development materials in a convenient, inexpensive and reliable format. The Digest is based around the RGH Pharmacy E-Bulletin, which will continue to be distributed free of charge in the usual way. (Click here to read the RGH announcement in full.) Click here to do this Continuing Education activity. AusPharm gratefully acknowledges the financial support provided by the sponsors of our CE program, MIMS and The Australian Medicines Handbook (AMH).
Click here to do this Continuing Education activity.
Learning objectives After completing this activity, pharmacists should be able to:
Most Australians do not undertake sufficient daily physical activity. In 2004–2005, 70% of Australians aged 15 years and over (who were surveyed in the National Health Survey) were classified as being sedentary or having low levels of physical activity. Women were more likely to be sedentary or have low levels of physical activity compared with men (73% versus 66%). Physical inactivity was estimated to account for 10.2% of total deaths and 6.6% of the total burden of disease and injury in the Australian population in 2003, which represents the fourth greatest cause of burden of disease among Australians. Click here to do this Continuing Education activity. AusPharm gratefully acknowledges the financial support provided by the sponsors of our CE program, MIMS and The Australian Medicines Handbook (AMH). Click here to do this Continuing Education activity.
Hyperhidrosis is a medical condition that causes unpredictable perspiration in excess of that required for normal thermoregulation, as a result of the over-production of sweat by the sweat glands. Mr. BW, a regular customer to the pharmacy, came reporting a week ago that his wife Mrs. VW, aged 64 years, has been sweating profusely for the last few months, even though the weather has been quite mild. Click here to do this Continuing Education activity now. Not a 'premium' member? To upgrade now click here or to commence a free trial click here. To add your PSA, AACP or ACPPM member number to our database (so you can receive credit for completing this activity) click here. AusPharm gratefully acknowledges the financial support provided by the sponsors of our CE program, MIMS and The Australian Medicines Handbook (AMH).
Click here to do this Continuing Education activity.
After completing this activity, pharmacists should be able to:
AusPharm gratefully acknowledges the financial support provided by the sponsors of our CE program, MIMS and The Australian Medicines Handbook (AMH). Click here to do this Continuing Education activity. RGH Pharmacy E-Bulletin CPD Digest - Issue No 1 :: : 3/6/2008 : The RGH Pharmacy E-Bulletin CPD Digest is a new way for busy pharmacists, doctors and nurses to access high quality continuing professional development materials in a convenient, inexpensive and reliable format. The Digest will be based around the RGH Pharmacy E-Bulletin, which will continue to be distributed free of charge in the usual way. (Click here to read the RGH announcement in full.) This pilot will assess your understanding of four recent RGH Pharmacy E-Bulletins (Volumes 30:1 to 30:4, May 2008). You can access these E-Bulletins individually here or as a group here. We'd be delighted to receive feedback on how you find this CE activity. You can do this by commenting in the fields provided at the end of the multiple choice questions. For further information contact the RGH Pharmacy Department on 08 82751763 or email: chris.alderman@rgh.sa.gov.au. Click here to do this Continuing Education activity. Information in this E-Bulletin Digest is derived from critical analysis of available evidence – individual clinical circumstances should be considered when making treatment decisions. AusPharm gratefully acknowledges the financial support provided by the sponsors of our CE program, MIMS and The Australian Medicines Handbook (AMH).
Click here to do this Continuing Education activity.
Learning Objective:
The pharmacist should be able to apply evidence-based principles of pharmacotherapeutics to a practical example of a patient with dementia. Two weeks ago AusPharm ran the first part of this two part series on Dementia Participants will need to refer back to that activity and to other reference material (eg MIMs, AMH, eTG) in order to complete this case study. Select the most appropriate option for each of the questions below relating to the following case: One of your regular customers, Cheryl, comes into the pharmacy and presents an authority prescription for her mother, Evelyn Moss, who is 82 years old and lives with her husband in a small retirement unit. Cheryl tells you that her mum has just been switched over to Elexon (rivastigmine) from Aricept (donepezil) by the geriatrician. Cheryl said that her mother didn’t appear to improve on the Aricept and wants to know if the new medication is any ‘better’. She also mentions in passing that her father is finding it increasingly difficult to look after her mother. Click here to do this Continuing Education activity now. Not a 'premium' member? To upgrade now click here or to commence a free trial click here. To add your PSA, AACP or ACPPM member number to our database (so you can receive credit for completing this activity) click here. AusPharm gratefully acknowledges the financial support provided by the sponsors of our CE program, MIMS and The Australian Medicines Handbook (AMH).
Click here to do this Continuing Education activity.
After completing this activity, pharmacists should be able to:
A previous AusPharm Continuing Education activity focussed on medication causes of urinary incontinence (UI). (Mark, put link) That article identified the different types of urinary incontinence and reversible risk factors, and detailed medications that may cause or exacerbate this common condition. Click here to do this Continuing Education activity. AusPharm gratefully acknowledges the financial support provided by the sponsors of our CE program, MIMS and The Australian Medicines Handbook (AMH). Click here to do this Continuing Education activity.
The term ‘dementia’ refers to a significant loss of intellectual abilities such as memory capacity, severe enough to interfere with social or occupational functioning. Dementia is not a single specific disease and therefore affects each person differently with symptoms and disease progression varying between individuals. Click here to do this Continuing Education activity now. Click here to do this Continuing Education activity.
After completing this activity, pharmacists should be able to:
Over half a million people or 2.8% of the Australian adult population experience severe incontinence, and a further 723,100 people have moderate urinary incontinence i.e. urine leakage several times a month or less. Another 3 million Australians experience leakage less than once a month or may only leak a few drops. With over 3.8 million Australians having had some form of incontinence, chances are that you may see someone every day in the pharmacy with bladder or bowel problems. Click here to do this Continuing Education activity. AusPharm gratefully acknowledges the financial support provided by the sponsors of our CE program, MIMS and The Australian Medicines Handbook (AMH). Click here to do this Continuing Education activity.
Two weeks ago AusPharm ran the first part of this two part series on The Role of Drugs in Non-Infective Liver Disease. Participants may wish to refer back to that activity and/or to other reference material in order to complete this case study. Mr PT is a 72 year old man with advanced alcoholic liver disease, heart failure with permanent atrial fibrillation and severe pancreatitis resulting in diabetes. He has developed significant ascites, and has put on 9kg in weight over the past 2 months. In addition, Mr T is becoming increasingly confused and disorientated. His GP has arranged for an HMR to be undertaken. Click here to do this Continuing Education activity now. Not a 'premium' member? To upgrade now click here or to commence a free trial click here. To add your PSA, AACP or ACPPM member number to our database (so you can receive credit for completing this activity) click here. AusPharm gratefully acknowledges the financial support provided by the sponsors of our CE program, MIMS and The Australian Medicines Handbook (AMH).Click here to do this Continuing Education activity.
AusPharm gratefully acknowledges the financial support provided by the sponsors of our CE program, MIMS and The Australian Medicines Handbook (AMH). Click here to do this Continuing Education activity.
Two weeks ago AusPharm ran the first part of this two part series on Smoking Cessation. Participants may wish to refer back to that activity and/or to other reference material in order to complete this case study. Mr Brown is a 35 year old construction worker who presents to you in the pharmacy, for advice. He is requesting information on the smoking cessation products currently available. Click here to do this Continuing Education activity now. Not a 'premium' member? To upgrade now click here or to commence a free trial click here. To add your PSA, AACP or ACPPM member number to our database (so you can receive credit for completing this activity) click here. AusPharm gratefully acknowledges the financial support provided by the sponsors of our CE program, MIMS and The Australian Medicines Handbook (AMH). Click here to do this Continuing Education activity.
After completing this activity, pharmacists should be able to:
Restless legs syndrome (RLS) is a common disorder in the older person, characterized by an almost irresistible urge to move the legs. The unpleasant sensations frequently cause difficulties in falling asleep. RLS is estimated to affect 5 to 10 percent of the population, affects more women than men, and seems to increase with age. Restless legs syndrome can have a detrimental effect on sleep, cognition, quality of life and mental status. Click here to do this Continuing Education activity.
Click here to do this Continuing Education activity.
After completing this activity, pharmacists should: 1. understand the prevalence and consequences of smoking;2. understand the key pharmacological approaches in smoking cessation; and 3. be able to advise on appropriate management techniques for use in different categories of patients for smoking cessation.
Smoking is a key risk factor for the three diseases that cause the most deaths in Australia: ischaemic heart disease, cerebrovascular disease and lung cancer. Cardiovascular disease is the leading cause of death in Australia, and around 13% of deaths from cardiovascular disease are caused by tobacco smoking. Nearly 40% of all people who die from smoking die from heart disease, stroke and blood vessel (cardiovascular) disease. Smoking increases the risk of myocardial infarction and stroke to 3 to 4 times that of non-smokers and accelerates the decline of lung function over time.
Click here to do this Continuing Education activity.
The pharmacist should be able to apply evidence-based principles of pharmacotherapeutics for heart failure to a practical example. Two weeks ago AusPharm ran the first part of this two part series on Heart Failure. Participants may wish to refer back to that activity and/or to other reference material in order to complete this case study. Mrs. Kline, a 74-year-old woman, is a newly admitted resident in an aged care facility. She has a past history of hypertension, ischaemic heart disease and congestive heart failure. Her current medications are aspirin 100 mg daily, diltiazem SR 180 mg daily, frusemide 40 mg bd, glyceryl trinitrate spray prn, and docusate with senna prn. Click here to do this Continuing Education activity now. Not a 'premium' member? To upgrade now click here or to commence a free trial click here. To add your PSA, AACP or ACPPM member number to our database (so you can receive credit for completing this activity) click here. AusPharm gratefully acknowledges the financial support provided by the sponsors of our CE program, MIMS and The Australian Medicines Handbook (AMH). Click here to do this Continuing Education activity.
On completing this education activity pharmacists should:
Calcium it is critically important for bone health and the average person consumes levels of calcium far below the recommended daily amount. More than half of Australian adults do not reach their recommended daily intake of calcium. It has been estimated that 85% of females after childhood fail to get the recommended intake of calcium. The required daily calcium allowance for most adults is 1000mg and 1300mg is recommended for people over 70 years.
Click here to do this Continuing Education activity.
After completing this activity, pharmacists should be able to:
Heart failure (HF) describes conditions when the heart functions less effectively to pump blood around the body.1 Heart failure usually develops slowly, as the heart becomes weaker and works less effectively. People with mild or early HF often have few symptoms, but in more severe cases it can result in lethargy, shortness of breath on exertion and fluid overload.
Click here to do this Continuing Education activity.
Learning Objectives: On completing this activity pharmacists should be able to:
AusPharm gratefully acknowledges the financial support provided by the sponsors of our CE program, MIMS and The Australian Medicines Handbook (AMH). Click here to do this Continuing Education activity.
The pharmacist should be able to apply evidence-based principles of pharmacotherapeutics to a practical example. Two weeks ago AusPharm ran the first part of this two part series on Insomnia. Today's Continuing Education Activity is a Case Study: Mrs. Farmer, a 71-year-old woman who lives alone, has presented to her family doctor complaining of difficulty with getting to sleep. Her husband died, after battling cancer, about 6 months ago, which is when her insomnia had begun. AusPharm gratefully acknowledges the financial support provided by the sponsors of our CE program, MIMS and The Australian Medicines Handbook (AMH). Click here to do this Continuing Education activity.
Vitamin D was considered by Time to be one of the Top Ten Medical Breakthroughs for 2007. Vitamin D’s main role is to maintain calcium levels in the blood to maintain a wide variety of functions in the body, include bone health. But a large number of studies published in 2007 suggest that the vitamin may play a role in the prevention and treatment of a wide range of the conditions – diabetes, multiple sclerosis, cancer, falls, asthma, epilepsy, pre-menstrual syndrome, rheumatoid arthritis, cardiovascular disease, hypertension, and lipid levels.
Click here to do this Continuing Education activity.
Learning Objectives
On completion of this module, the pharmacist should be able to discuss: (i) the prevalence, causes (including drug-related) and consequences of insomnia; Insomnia has been described as an “under-appreciated public health issue”. It is estimated that almost 1.5 million GP visits each year are associated with insomnia and that approximately 5% of Australians suffer from chronic insomnia, with a similar level of usage of hypnotics.
Click here to do this Continuing Education activity.
Sir Arthur Hurst, 1935
Constipation is a common complaint amendable to self-treatment in addition to medical treatment. Many consumers will not discuss constipation with their medical practitioners, preferring to self-manage with over-the-counter and complementary medicines. Community pharmacists have frequent opportunities to identify medications and conditions that may be contributing to constipation, discuss appropriate management with patients, and ensure evidence-based drug therapy is used.
Click here to do this Continuing Education activity. These activities will take approximately 30 minutes to complete and has been formally recognised by the Pharmaceutical Society of Australia (Recognition No: CR08-0012 : 1 CPD&PI point), The Australian Association of Consultant Pharmacy and The Australian College of Pharmacy Practice and Management. To add your PSA, AACP or ACPPM member number to our database (so you can receive credit for completing this activity) click here. |
|||||||||||
All images copyright © www.auspharm.net.au pty ltd, 2010, or their respective owners.
'premium' content
This activity has been accredited by the Pharmaceutical Society of Australia as a Group 2 activity for 1 point. Accreditation number: CX100003n.
AusPharm gratefully acknowledges the financial support provided by the sponsors of our CE program, 
Welcome to Issue No 27 of the RGH Pharmacy E-Bulletin CPD Digest.
AusPharm gratefully acknowledges the financial support provided by the sponsors of our CE program, 
This activity has been accredited by the Pharmaceutical Society of Australia as a Group 2 activity for 0.75 points. Accreditation number: CX100003g.
Welcome to Issue No 18 of the RGH Pharmacy E-Bulletin CPD Digest. The topics covered in this issue are:
This activity has been accredited by the Pharmaceutical Society of Australia as a Group 2 activity for 0.75 point. Accreditation number:CX09048e.
AusPharm gratefully acknowledges the financial support provided by the sponsors of our CE program, 
Statins and haemorrhagic stroke risk
This activity has been accredited by the Pharmaceutical Society of Australia as a Group 2 activity for 0.75 point. Accreditation number: CX090022s.
AusPharm gratefully acknowledges the financial support provided by the sponsors of our CE program, 
AusPharm gratefully acknowledges the financial support provided by the sponsors of our CE program, 
Welcome to Issue No 10 of the RGH Pharmacy E-Bulletin CPD Digest. The topics covered in Issue No 10 are:
This activity has been accredited by the Pharmaceutical Society of Australia as a Group 2 activity for .75 points. Accreditation number: CX090022e.
Apply a working knowledge of the clinical pharmacology of rivaroxaban
As Christmas approaches it seems only reasonable that we do a CE activity on chocolate. Thanks for putting this together for us Debbie. 
Welcome to our 'pilot' of the RGH Pharmacy E-Bulletin CPD Digest.
